bpc 157 human clinical trial This doesn't mean BPC-157 is side-effect-free. But it does add to the safety signal. Credit to @dr.kseniamiami for mentioning this study on our recent podcast recording last week which will be out What no one's telling you
Description
Applying the products stated 5:1:1 ratio to each 2,330 mcg dose implies roughly 1.67 mg GHK-Cu + 0.33 mg TB-500 + 0.33 mg BPC-157 per injection
Noboth peptides require subcutaneous injection for bioavailability
These formulas are developed by focusing on measurable results, specifically addressing their unique health needs and goals
TAM: F (1,21) = 15.23, p = 0.0008
Some patients may require laboratory testing before treatment, while others may not
